The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia. [electronic resource]
Producer: 20180221Description: 2313-2324 p. digitalISSN:- 1557-3265
- Adenine -- analogs & derivatives
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Apoptosis -- drug effects
- B-Lymphocytes -- drug effects
- Bridged Bicyclo Compounds, Heterocyclic -- administration & dosage
- Flow Cytometry
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Janus Kinase Inhibitors -- administration & dosage
- Janus Kinases -- antagonists & inhibitors
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Leukocytes, Mononuclear -- drug effects
- Neoplasm Proteins -- genetics
- Piperidines
- Proto-Oncogene Proteins c-bcr -- antagonists & inhibitors
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
- Receptors, Antigen, B-Cell -- drug effects
- Signal Transduction -- drug effects
- Sulfonamides -- administration & dosage
- Sulfones -- administration & dosage
- Syk Kinase -- antagonists & inhibitors
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.